Avricore Health (AVCRF) Return on Sales (2009 - 2026)

Avricore Health (AVCRF) has reported Return on Sales for 17 consecutive years, with 0.05% the latest figure, recorded in Q2 2026.

• In Q2 2026, Return on Sales rose 11.0% year-over-year to 0.05%; the TTM figure through Jun 2026 stood at 0.07% (down 7.0% YoY), while the FY2025 annual figure was 0.03%, down 3.0% from the prior year.
• Return on Sales climbed to 0.05% in Q2 2026 per AVCRF's latest filing, from 0.13% in the prior quarter.
• Across five years, Return on Sales topped out at 0.0% in Q1 2024 and bottomed at 0.16% in Q2 2025.
• Historically, Return on Sales has averaged 0.03% across 5 years, with a median of 0.0% in 2022.
• Annual changes were most pronounced in 2025 — Return on Sales decreased 16 bps — and 2026, when it advanced 11 bps.
• Avricore Health's Return on Sales stood at 0.0% in 2022, then soared by 121 bps to 0.0% in 2023, then plunged by 207 bps to 0.0% in 2024, then tumbled by 24312 bps to 0.13% in 2025, then surged by 59 bps to 0.05% in 2026.
• Business Quant data shows AVCRF's Return on Sales at 0.05% in Q2 2026, 0.13% in Q4 2025, and 0.1% in Q3 2025.